The adverse issue is cash. I don't think there is anything sinister... it's all happening pretty fast, and getting things organised takes time, especially when you're trying (wanting) to run a business, talk to pharmacy chains, sort out manufacturing supply and (I hope) roasting your customer service people. PP/SS covered the shortfall, then the convertible loan...with the plan that the next raise and subsequent use of GEM will cover cash through to all of us understanding if sales get traction. If sales don't get traction ... or they can't demonstrate this or why it will, then the raise from soph's will be pretty challenging and then that's the game. But, if traction can be demonstrated... and the device numbers from the 4E do provide hope, then I think PP will get that across the line and the game will enter a new phase (still no guarantees).
PP has dragged the business a long way. But it's up a windy difficult path with very steep sides. I'm glad he's giving it a go!
- Forums
- ASX - By Stock
- WFL
- Ann: Letter to Shareholders, General Meeting Notice & Proxy Form
Ann: Letter to Shareholders, General Meeting Notice & Proxy Form, page-109
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add WFL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.478M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
WFL (ASX) Chart |
Day chart unavailable